Keros Therapeutics Inc (KROS)’s Ratio Roundup: Key Metrics for Trailing Twelve Months
Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth. As of close of business last night, Keros Therapeutics Inc’s stock clocked out at $54.54, down -2.26% from its previous closing price of $55.80. In other words, the […]
